Biomarkers of acute kidney injury in neonatal encephalopathy
- 823 Downloads
Acute kidney injury (AKI) is a common complication of neonatal encephalopathy (NE). The accurate diagnosis of neonatal AKI, irrespective of the cause, relies on suboptimal methods such as identification of rising serum creatinine, decreased urinary output and glomerular filtration rate. Studies of AKI biomarkers in adults and children have shown that biomarkers can improve the early diagnosis of AKI. Hypoxia–ischaemia is the proposed aetiological basis of AKI in both NE and cardiopulmonary bypass (CPB). However, there is a paucity of studies examining the role of AKI biomarkers specifically in NE. Urinary cystatin C (CysC), neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18, kidney injury molecule-1, liver-type fatty acid-binding protein, serum CysC and serum NGAL all show good ability to predict early AKI in a heterogeneous critically ill neonatal population including infants post-CPB. Moreover, serum and urinary NGAL and urinary CysC are early predictors of AKI secondary to NE. These findings are promising and open up the possibility of biomarkers playing a significant role in the early diagnosis and treatment of NE-related AKI. There is an urgent need to explore the role of AKI biomarkers in infants with NE as establishing the diagnosis of AKI earlier may allow more timely intervention with potential for improving long-term outcome.
KeywordsHypoxic–ischaemic encephalopathy Neutrophil gelatinase-associated lipocalin Cystatin C Interleukin-18 Kidney injury molecule-1 Liver-type fatty acid-binding protein
Conflict of interest
The authors declare that they have no conflict of interest.
- 11.Demirel G, Celik IH, Canpolat FE, Erdeve O, Biyikli Z, Dilmen U (2012) Reference values of serum cystatin C in very low birth weight premature infants. Acta Paediatr. Sept 27 [Epub ahead of print]Google Scholar
- 30.Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, Ishimitsu T, Numabe A, Takagi M, Hayakawa H, Tabei F, Sugimoto T, Mise N, Omata M, Kimura K (2006) Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284(1–2):175–182PubMedCrossRefGoogle Scholar
- 38.Liang XL, Liu SX, Chen YH, Yan LJ, Li H, Xuan HJ, Liang YZ, Shi W (2010) Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case–control study. Biomarkers 15(4):332–339PubMedCrossRefGoogle Scholar
- 39.Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL (2007) Urinary N-acetyl-beta-(d)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18(3):904–912PubMedCrossRefGoogle Scholar
- 47.Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalin–siderophore–iron complex rescues the kidney from ischemia–reperfusion injury. J Clin Invest 115(3):610–621PubMedGoogle Scholar
- 63.VandeVoorde RG et al (2006) Serum NGAL and cystatin C as predictive biomarkers for acute kidney injury. J Am Soc Nephrol 17:404AGoogle Scholar